Disease [− health state] | Adjusted YLD/1000 cases (95% UI) | Unadjusted YLD/1000 cases (95% UI) | Overestimation of YLD (95% UI) | Difference in YLD/1000 cases |
---|---|---|---|---|
Colorectal cancer (All health states) | 471.7 (447.8–496.8) | 473.3 (449.2–498.9) | 0.3% | 1.6 |
– Diagnosis/therapy only | 309.4 (291.8–329.9) | 310.5 (292.8–331.1) | 0.4% | 1.1 |
– Pre-terminal/ terminal only | 163.5 (147.4–178.7) | 164.0 (148.0–179.2) | 0.3% | 0.5 |
HAP co-existent with colorectal cancer (All health states) | 73.0 (51.4–98.1) | 75.3 (52.8–102.0) | 3.0% | 2.3 |
– Symptomatic infection | 0.4 (0.3–0.5) | 0.4 (0.3–0.5) | 9.9% | 0.0 |
– Severe sepsis, septic shock | 1.1 (0.8–1.5) | 1.4 (0.9–1.9) | 25.5% | 0.3 |
– PTSD | 17.4 (8.1–28.8) | 18.1 (8.4–29.8) | 3.9% | 0.7 |
– Cognitive impairment | 14.4 (8.7–21.1) | 14.8 (8.9–21.7) | 3.0% | 0.4 |
– Physical impairment | 36.2 (28.0–45.4) | 36.7 (28.4–46.0) | 1.4% | 0.5 |
– Renal failure & renal replacement therapy | 4.2 (0–13.8) | 4.5 (0–4.5) | 7.9% | 0.3 |